Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
JCR Pharmaceuticals Co Ltd
4552Current price
649 JPY
-5 JPY (-0.76%)
Last closed
651 JPY
Company
www.jcrpharm.co.jp
ISIN
JP3701000006
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
Tokyo Stock Exchange
Capitalization
80 185 383 752 JPY
Yield for 12 month
-48.82 %
1Y
3Y
5Y
10Y
15Y
4552
JCR Pharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V. Infusion used for the treatment of Fabry disease; and TEMCELL HS Inj used to treat acute graft-versus-host disease. The company develops Epoetin Alfa BS and Darbepoetin Alfa BS Injections for the treatment of renal anemia. In addition, it sells, imports, and exports medical devices and laboratory instruments; and purchases and sells medical and research equipment. The company has a collaboration agreement with Angelini Pharma for the development of novel biologic therapies; and a. joint research agreement with Modalis Therapeutics Corporation to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. JCR Pharmaceuticals Co., Ltd. was incorporated in 1975 and is headquartered in Ashiya, Japan. Address: 3-19 Kasuga-cho, Ashiya, Japan, 659-0021
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
134 071.71 JPYP/E ratio
–Dividend Yield
3.26 %Current Year
+42 534 331 685 JPY
Last Year
+34 073 302 531 JPY
Current Quarter
+8 445 154 796 JPY
Last Quarter
+8 081 036 843 JPY
Current Year
+31 005 584 079 JPY
Last Year
+25 257 084 711 JPY
Current Quarter
+6 205 879 092 JPY
Last Quarter
+5 811 996 797 JPY
Key Figures 4552
1 year
3 years
5 years
10 years
EBITDA
3 299 880 849 JPY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-0.12 %
PEG Ratio
–
Return On Equity TTM
-0.71 %
Wall Street Target Price
134 071.71 JPY
Revenue TTM
34 979 133 155 JPY
Book Value
448.28 JPY
Revenue Per Share TTM
Dividend Share
19.84 JPY
Quarterly Revenue Growth YOY
-36.8 %
Dividend Yield
3.26 %
Gross Profit TTM
40 302 001 000 JPY
Earnings per share
-3.47 JPY
Diluted Eps TTM
-3.47 JPY
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
-87.5 %
Profit Margin
-1.24 %
Dividend Analytics 4552
Dividend growth over 5 years
196 %Continuous growth
2 yearsPayout Ratio 5 years average
43 %Dividend History 4552
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
20
Ex Dividend Date
28.03.2025
Forward Annual Dividend Yield
3.08 %
Last Split Factor
4:1
Payout Ratio
61.2 %
Last Split Date
30.09.2020
Dividend Date
–
Stock Valuation 4552
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
23.2558
Enterprise Value Revenue
2.4391
Price Sales TTM
2.2924
Enterprise Value EBITDA
26.822
Price Book MRQ
1.4499
Financials 4552
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 4552
For 52 weeks
455.66 JPY
1 294.27 JPY
50 Day MA
659.2 JPY
Shares Short Prior Month
–
200 Day MA
705.98 JPY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart